Search Results
Ordered by: Date (newest first) / Date (oldest first)
DuPont and Monsanto settle Roundup dispute
12 April 2013 Business
Firms drop expensive ongoing litigation in favour of a licensing deal
Interpol teams up with pharma
18 March 2013 Business
Pharmaceutical crime programme will seek to reduce trade in fake drugs
Dow makes $1.5bn divestiture plans
15 March 2013 Business
Liveris in favour of 'selectively pruning' further non-core units
Dispute over Arkema finances
13 March 2013 Business
French speciality chemical company Arkema accused of misrepresenting business sold to investment firm last year
Alcohol dependence pill approved in EU
5 March 2013 Business
Selincro tablets from Lundbeck designed to reduce consumption of alcohol
University to acquire Shell UK R&D site
5 March 2013 Business
Site at Thornton will become a science park under the stewardship of the University of Chester
Dow rapped for $1bn tax scheme
1 March 2013 Business
Judge opines: 'tax law deals in economic realities, not legal abstractions'
Does chemical regulation boost innovation?
28 February 2013 Business
Report suggests that supply of innovation responds to extra demand created by new laws
Talk of a $6.6bn deal for Elan
27 February 2013 Business
Potential offer from Royalty Pharma comes as Elan ponders how to spend its cash from Tysabri rights
$595m octreotide deal grabs Roche
21 February 2013 Business
Company will get worldwide rights to oral formulation of growth hormone drug
Merck resolves Vytorin case for $688m
19 February 2013 Business
Investors say the company knew about Enhance trial failure but withheld information
BMS sells OTC drugs for $482m
14 February 2013 Business
Bristol-Myers Squibb will offload rights to a range of over-the-counter products to Reckitt Benckiser
Ozone device for food packaging
12 February 2013 Business
Device uses plasma to create ozone inside sealed packaging
Biogen buys Tysabri from Elan for $3.25bn
8 February 2013 Business
Elan earns huge cash injection for blockbuster drug
BASF drops GM potato projects
7 February 2013 Business
Move follows transfer of R&D from Europe to US
Reach reviewed: no change required
6 February 2013 Business
But disproportionate cost of compliance for small and medium size companies should be reduced, European commission says
Zoetis IPO launches at $2.2bn
1 February 2013 Business
Pfizer spin off will be a big player among a relatively small number of public companies focusing on animal heatlh
DCD in New Zealand milk
31 January 2013 Business
Dicyandiamide poses no food risk but fertiliser companies have suspended sales
Sabic invests $500m in new R&D centres
30 January 2013 Business
Four centres to be created: two in Saudi Arabia, one in India and one in China
Allergan buys MAP for $958m
25 January 2013 Business
Deal strengthens Allergan's position in neurology with Levadex for treating migraine
OM Group to exit cobalt business
24 January 2013 Business
Deal worth up to $435 million includes downstream activities, in particular cobalt refining in Kokkola, Finland
Vasella to leave Novartis in August
24 January 2013 Business
Long serving chair of the board of directors will be succeeded by Jörg Reinhardt
Flu vaccine without the eggs approved
22 January 2013 Business
Flublok does not require flu virus or eggs for manufacture
UK companies struggling with Reach
16 January 2013 Business
Regulation is 'elephant in the room' as manufacturers fail to recognise implications
Selected Filters
Filter Results
Article type
- Business (156)
- News Archive (43)
- News and Analysis (3)
- Feature (2)
- Jobs Profile (Company) (1)
- Comments (1)
Author
Date range
Custom date range